by Amy DuRoss | October 13, 2020
Vineti, Inc., the leading digital platform of record for personalized therapeutics, today announced the closing of a $33 million extension to its Series C financing. The new financing will support further expansion of the company’s Personalized…
by Amy DuRoss | October 7, 2020
by Vineti | October 7, 2020
This year’s “Mesa” will be entirely virtual. Vineti completely supports that decision amid the ongoing threat from COVID-19. And yet we also wanted to take a minute to acknowledge what we’ll all miss -- the chance for serendipitous connections and…
OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies
by Vineti | August 25, 2020
Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer patients.
by Amy DuRoss | August 17, 2020
Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene therapies.